Table 2.
Impact of anti-AMPA antibodies in the CNS: preclinical evidences.
| Source | Targeted GluA Subunit | Experimental Paradigm |
Effects | Reference |
|---|---|---|---|---|
| Serum of rabbits immunized with a specific amino acid sequence of the GluR3 protein (the Glu3B peptide, aa 372–395) Purified IgG anti-GluA3 autoantibodies Serum from patients with active Rasmussen’s |
GluA3 | Cultured fetal mouse cortical neurons | ↑ Currents in neurons, prevented by CNQX The GluR3B peptide specifically blocks the antisera- and IgG-evoked currents The anti-GluR3B antibody mimics the serum from immunized rabbit and the purified IgG. |
[73] |
| Murine antibody recognizing a specific sequence of the GluR3 protein (the Glu3B peptide, aa 372–395) | GluA3 | Mouse coronal slices of somatosensory cortex Primary hippocampal cultures |
Immunostaining of neurons ↑ CNQX-sensitive currents in neurons GluR3B peptide-induced neuronal death reduced by CNQX |
[105] |
| Anti-GluA3 IgG isolated from GluA3 (aa 246–455)-immunized rabbits | GluA3 | Rat mixed cortical neuronal and glial cultures Whole cell recording in cultured rat cortical neurons |
↑ Release of LDH from mixed cultures in a GIKY52466 or CNQX-independent manner The plasma from immunized animals does not evoke currents in cultured neurons |
[112] |
| Purified rabbit antibody recognizing a specific amino acid sequence of the GluR3 protein (the Glu3B peptide, aa 372–395) Monoclonal mouse anti-GluA3B |
GluA3 | Rat brain homogenates Xenopus laevi oocytes expressing GluA3 homomeric or GluA2/A3 heteromeric AMPARs |
Purified rabbit anti-GluA3 antibody elicits whole cell currents that were sensitive to CNQX | [98] |
| Murine anti-autoantibody recognizing the amino acid sequence of the GluR3 protein (the Glu3B peptide, aa 372–395) | GluA3 | DBA/2J mice immunized with the GluR3B peptide that express circulating anti-GluA3B autoantibodies | Immunized DBA/2J mice were more susceptible to pentetrazol-induced seizures | [106] |
| Serum and CSF containing anti-GluA3 autoantibodies from patients suffering from FTD | GluA3 | Rat hippocampal neuronal primary cultures differentiated neurons from human-induced pluripotent stem cells (hIPSC) |
↓ GluA3 subunit synaptic localization of AMPA receptor in hippocampal neuronal primary cultures ↓ Dendritic spines AMPA receptor in cultured hippocampal neurons ↓ GluA3 subunit fraction in the postsynaptic fraction of cultured hIPSC |
[58] |
| Serum of patients suffering from FTD-Tau neuropathology with a high titer of anti-GluA3 autoantibody | GluA3 | Mouse cortical synaptosomes | The serum does not evoke glutamate exocytosis ↓ AMPA-evoked glutamate release |
[103] |
| Commercial anti-GluA3 antibody | GluA3 | Mouse cortical synaptosomes | ↑ GluA2 and GluA3 subunits insertion in synaptosomal plasma membranes The antibody does not evoke glutamate exocytosis ↑ AMPA-evoked glutamate release |
[104] |
| IgG Anti-GluA3 antibody from rabbit immunized with the GluR3B peptide |
GluA3 | Mouse whole brain lysates Primary hippocampal neurons |
Anti-GluA3 immunostaining in the whole brain lysate ↓ excitatory postsynaptic currents (EPSCs) in primary hippocampal neurons |
[108] |
| Serum of a patient suffering from progressive sporadic olivopontocerebellar atrophy Purified IgM anti-GluA2 autoantibodies |
GluA2 | Cultured fetal mouse cortical neurons | ↑ Currents in neurons in a CNQX-sensitive manner Currents were blocked by a synthetic peptide corresponding to the specific epitope region of GluR2 (aa 369–393) |
[111] |
| Purified IgM anti-GluA1 and GluA2 autoantibodies from the CSF of patients suffering from anti-AMPA receptor encephalitis Commercial anti-GluA1 and GluA2 antibody |
GluA2 | Primary rat hippocampal neuron and astrocyte cocultures | ↓ Surface AMPA receptor protein and synaptic localization Unmodified glutamatergic synapse density and cell viability ↑ Internalization of AMPA receptor clusters ↓ Miniature excitatory postsynaptic currents (mEPSCs) ↓ Miniature inhibitory postsynaptic currents (mIPSCs) ↑Intrinsic neuronal excitability after 48 h of treatment with patient CSF Commercial anti-GluA2 antibody does not cause receptor internalization |
[102] |
| Anti-GluA2 autoantibodies purified from patients suffering from limbic encephalitis | GluA2 | Human embryonic kidney 293 (HEK293) cells | ↓ GluA2-containing AMPA receptor clusters number at synapses with a smaller decrease in overall AMPA receptor cluster density | [101] |
| Commercial anti-GluA2 antibody | GluA2 | Mouse cortical synaptosomes | ↑ Insertion of GluA2 and GluA3 subunits in synaptosomal plasma membranes The anti-GluA2 antibody does not evoke glutamate exocytosis ↑ AMPA-evoked glutamate release |
[104] |
| Purified IgM anti-GluA1 autoantibodies from the CSF of anti-AMPA receptor encephalitis patients Commercial anti-GluA1 antibody |
GluA1 | Primary rat hippocampal neuron and astrocyte cocultures | ↓ Localization of synaptic surface AMPA receptor protein The anti-GluA1 antibody does not modify the glutamatergic synapse density and the cell viability ↑ Internalization of AMPA receptor clusters ↓ Miniature excitatory postsynaptic currents (mEPSCs) ↓ Miniature inhibitory postsynaptic currents (mIPSCs) ↑ Intrinsic neuronal excitability after 48 h of treatment with patient CSF Commercial anti-GluA1 antibody does not cause receptor internalization |
[102] |
| Commercial anti-GluA1 antibody | GluA1 | Mouse cortical synaptosomes | The anti-GluA1 antibody does not evoke glutamate exocytosis The anti-GluA1 antibody does not modify the AMPA-evoked glutamate release |
[104] |